NUS Liabilities And Stockholders Equity from 2010 to 2025

NUS Stock  USD 6.85  0.49  6.68%   
Nu Skin Liabilities And Stockholders Equity yearly trend continues to be comparatively stable with very little volatility. Liabilities And Stockholders Equity will likely drop to about 1.2 B in 2025. Liabilities And Stockholders Equity is the total of all liabilities and equity in the company, which should equal Nu Skin's total assets according to the accounting equation. View All Fundamentals
 
Liabilities And Stockholders Equity  
First Reported
1995-12-31
Previous Quarter
1.6 B
Current Value
1.5 B
Quarterly Volatility
549.6 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Nu Skin financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nu Skin's main balance sheet or income statement drivers, such as Depreciation And Amortization of 51.2 M, Interest Expense of 27.7 M or Total Revenue of 1.8 B, as well as many indicators such as Price To Sales Ratio of 0.19, Dividend Yield of 0.0206 or PTB Ratio of 0.5. NUS financial statements analysis is a perfect complement when working with Nu Skin Valuation or Volatility modules.
  
Check out the analysis of Nu Skin Correlation against competitors.

Latest Nu Skin's Liabilities And Stockholders Equity Growth Pattern

Below is the plot of the Liabilities And Stockholders Equity of Nu Skin Enterprises over the last few years. It is the total of all liabilities and equity in the company, which should equal the company's total assets according to the accounting equation. Nu Skin's Liabilities And Stockholders Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nu Skin's overall financial position and show how it may be relating to other accounts over time.
Liabilities And Stockholders Equity10 Years Trend
Slightly volatile
   Liabilities And Stockholders Equity   
       Timeline  

NUS Liabilities And Stockholders Equity Regression Statistics

Arithmetic Mean1,491,546,874
Geometric Mean1,323,748,018
Coefficient Of Variation30.97
Mean Deviation321,272,908
Median1,614,434,000
Standard Deviation461,969,702
Sample Variance213416T
Range1.8B
R-Value0.52
Mean Square Error166038.7T
R-Squared0.27
Significance0.04
Slope50,779,155
Total Sum of Squares3201240.1T

NUS Liabilities And Stockholders Equity History

20251.2 B
20241.5 B
20231.8 B
20221.8 B
20211.9 B
2020B
20191.8 B

About Nu Skin Financial Statements

Nu Skin shareholders use historical fundamental indicators, such as Liabilities And Stockholders Equity, to determine how well the company is positioned to perform in the future. Although Nu Skin investors may analyze each financial statement separately, they are all interrelated. The changes in Nu Skin's assets and liabilities, for example, are also reflected in the revenues and expenses on on Nu Skin's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Liabilities And Stockholders Equity1.5 B1.2 B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for NUS Stock Analysis

When running Nu Skin's price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.